Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Photodynamic therapy for bile duct invasion of hepatocellular carcinoma.

Bahng S, Yoo BC, Paik SW, Koh KC, Lee KT, Lee JK, Lee JH, Choi MS, Lee KH.

Photochem Photobiol Sci. 2013 Mar;12(3):439-45. doi: 10.1039/c2pp25265a.

PMID:
23175171
2.

Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study.

Wiedmann M, Caca K, Berr F, Schiefke I, Tannapfel A, Wittekind C, Mössner J, Hauss J, Witzigmann H.

Cancer. 2003 Jun 1;97(11):2783-90.

3.

Biliary drainage, photodynamic therapy and chemotherapy for unresectable cholangiocarcinoma with jaundice.

Fuks D, Bartoli E, Delcenserie R, Yzet T, Celice P, Sabbagh C, Chatelain D, Joly JP, Cheron N, Dupas JL, Regimbeau JM.

J Gastroenterol Hepatol. 2009 Nov;24(11):1745-52. doi: 10.1111/j.1440-1746.2009.05915.x. Epub 2009 Sep 25.

PMID:
19780885
4.

Feasibility and safety of long-term photodynamic therapy (PDT) in the palliative treatment of patients with hilar cholangiocarcinoma.

Höblinger A, Gerhardt T, Gonzalez-Carmona MA, Hüneburg R, Sauerbruch T, Schmitz V.

Eur J Med Res. 2011 Sep 12;16(9):391-5.

5.
6.

Effectiveness of endoscopic biliary drainage for unresectable hepatocellular carcinoma associated with obstructive jaundice.

Matsueda K, Yamamoto H, Umeoka F, Ueki T, Matsumura T, Tezen T, Doi I.

J Gastroenterol. 2001 Mar;36(3):173-80.

PMID:
11291880
7.

Hepatocellular carcinoma with tumor thrombi in the bile duct.

Wang HJ, Kim JH, Kim JH, Kim WH, Kim MW.

Hepatogastroenterology. 1999 Jul-Aug;46(28):2495-9.

PMID:
10522026
8.

Biliary drainage for obstructive jaundice caused by unresectable hepatocellular carcinoma: the endoscopic versus percutaneous approach.

Choi J, Ryu JK, Lee SH, Ahn DW, Hwang JH, Kim YT, Yoon YB, Han JK.

Hepatobiliary Pancreat Dis Int. 2012 Dec 15;11(6):636-42.

PMID:
23232636
9.

Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection.

Witzigmann H, Berr F, Ringel U, Caca K, Uhlmann D, Schoppmeyer K, Tannapfel A, Wittekind C, Mossner J, Hauss J, Wiedmann M.

Ann Surg. 2006 Aug;244(2):230-9.

10.

Photodynamic therapy for unresectable cholangiocarcinoma.

Tomizawa Y, Tian J.

Dig Dis Sci. 2012 Feb;57(2):274-83. doi: 10.1007/s10620-011-1957-7. Epub 2011 Nov 6. Review. Erratum in: Dig Dis Sci. 2012 May;57(5):1423.

PMID:
22057285
11.

Adjuvant photodynamic therapy for bile duct carcinoma after surgery: a preliminary study.

Nanashima A, Yamaguchi H, Shibasaki S, Ide N, Sawai T, Tsuji T, Hidaka S, Sumida Y, Nakagoe T, Nagayasu T.

J Gastroenterol. 2004 Nov;39(11):1095-101.

PMID:
15580404
12.

Invasion of the lumen of the bile ducts by hepatocellular carcinoma.

Carella G, Degott C, Benhamou JP.

Liver. 1981 Dec;1(4):251-4.

PMID:
6294440
13.

Clinicopathologic evaluation of hepatocellular carcinoma with bile duct thrombi.

Satoh S, Ikai I, Honda G, Okabe H, Takeyama O, Yamamoto Y, Yamamoto N, Iimuro Y, Shimahara Y, Yamaoka Y.

Surgery. 2000 Nov;128(5):779-83.

PMID:
11056440
14.

Surgical results for hepatocellular carcinoma with bile duct invasion: a clinicopathologic comparison between macroscopic and microscopic tumor thrombus.

Esaki M, Shimada K, Sano T, Sakamoto Y, Kosuge T, Ojima H.

J Surg Oncol. 2005 Jun 15;90(4):226-32.

PMID:
15906365
15.

Transcatheter hepatic arterial embolization followed by microwave ablation for hemobilia from hepatocellular carcinoma.

Takao Y, Yoshida H, Mamada Y, Taniai N, Bando K, Tajiri T.

J Nippon Med Sch. 2008 Oct;75(5):284-8.

16.

Clinicopathologic characteristics of hepatocellular carcinoma with bile duct invasion.

Ikenaga N, Chijiiwa K, Otani K, Ohuchida J, Uchiyama S, Kondo K.

J Gastrointest Surg. 2009 Mar;13(3):492-7. doi: 10.1007/s11605-008-0751-0. Epub 2008 Nov 15.

PMID:
19011945
17.

Intractable bile leakage after hepatectomy for hepatocellular carcinoma in 359 recent cases.

Sadamori H, Yagi T, Matsuda H, Shinoura S, Umeda Y, Fujiwara T.

Dig Surg. 2012;29(2):149-56. doi: 10.1159/000337313. Epub 2012 May 3.

PMID:
22555445
18.

Success of photodynamic therapy in palliating patients with nonresectable cholangiocarcinoma: A systematic review and meta-analysis.

Moole H, Tathireddy H, Dharmapuri S, Moole V, Boddireddy R, Yedama P, Dharmapuri S, Uppu A, Bondalapati N, Duvvuri A.

World J Gastroenterol. 2017 Feb 21;23(7):1278-1288. doi: 10.3748/wjg.v23.i7.1278. Review.

19.

Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy.

Kahaleh M, Mishra R, Shami VM, Northup PG, Berg CL, Bashlor P, Jones P, Ellen K, Weiss GR, Brenin CM, Kurth BE, Rich TA, Adams RB, Yeaton P.

Clin Gastroenterol Hepatol. 2008 Mar;6(3):290-7. doi: 10.1016/j.cgh.2007.12.004. Epub 2008 Feb 6.

PMID:
18255347
20.

Hepatocellular carcinoma presenting as intrabile duct tumor growth: a clinicopathologic study of 24 cases.

Kojiro M, Kawabata K, Kawano Y, Shirai F, Takemoto N, Nakashima T.

Cancer. 1982 May 15;49(10):2144-7.

Supplemental Content

Support Center